Discussing the use of different expression formats, from transient through to stable clones, when using Chinese Hamster Ovary cells for biotherapeutic protein production, experts from Lonza and Denmark Technical University share the key considerations of selecting an expression format during biotherapeutic development, and how Lonza’s GS Discovery® solution addresses these.

Interviewee Biography

Peter O’Callaghan
Head of Expression System Sciences, Licensing & Biologics, Lonza

Bernadette Sweeney
Senior Director, Biologics R&D, Lonza

Kee Cheung
Senior Director, Regulatory Affairs, Lonza

Bjorn Gunnar Voldborg
Director, Cell Line and Protein Production Facility, Denmark Technical University